To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
ESG resolution round-up: Ambiguity around new Swiss law prompts confusion ahead of Novartis AGM
Novartis to put sustainability report up for advisory vote; Exxon lawsuit ‘a governance issue’ but investors remain quiet; Mirova makes third-party assurance demands.
